News
A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...
The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...
A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...
21h
Everyday Health on MSNNew FDA Panel Recommends Removing Warnings From Estrogen Therapies for MenopauseThe panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...
The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...
JUUL GETS ITS CROWN — The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining ...
2d
MedPage Today on MSNFDA Names Former Pharma Executive to Oversee U.S. Drug ProgramFDA Commissioner Marty Makary, MD, MPH, announced that George Tidmarsh, MD, PhD, a cancer and pediatric specialist, will ...
An article in The Journal For Nurse Practitioners found that Depo-Testosterone was the most cost-efficient TRT option, and ...
15h
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results